Stratum Biosciences

About Stratum Biosciences

Stratum Biosciences is dedicated to advancing human skin health by leveraging SkinSync™, the first AI platform focused on skin science. The company aims to translate deep biological insights into innovative skincare technologies, creating novel active ingredients and formulations to address dermatology challenges such as cellular aging, oxidative stress, and hyperpigmentation.

Products & Services

SkinSync™ Platform:An AI-powered platform for skin science that accelerates the design of novel active ingredients and optimizes their delivery through the skin barrier, delivering new product technologies over 5x faster.

Active Ingredients and Formulations:Includes longevity peptides, antioxidants, and other ingredients designed for greater speed and efficacy, optimized for bioavailability using a proprietary skin delivery database.

Specialties

AI in Skin Science Skin Health Innovation Topical Formulations Skin Barrier Research Active Ingredient Design Bioavailability Optimization

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 2000000 MR: - FA: $2M FAN: 2000000	D: 2026-03-27 FD: 2026-03-27	2 investors

Seed Latest

2026-03-27

$2.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ross L. Pearlman

Chief Executive Officer, Co-Founder

B

Buu T. Duong

President, Co-Founder

D

David Osborne

Chief Scientific Officer, Co-Inventor

J

John Koontz

Chief Technology Officer

View 1 more team members with Pro

Unlock Full Team Directory

Recent News